STOCK TITAN

Saba Capital (MBAV) reports 4.4M shared holdings, 13.94% stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

M3-Brigade Acquisition V Corp. Schedule 13G filed by Saba Capital discloses a shared beneficial interest of 4,401,171 shares in the issuer's Common Shares and Warrants, representing 13.94% based on March 12, 2026 data. The percentage denominator references 28,750,000 Shares outstanding as of March 12, 2026 and 2,816,171 Shares issuable upon exercise of certain warrants held by the reporting persons.

The reporting group comprises Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, who filed a Joint Filing Agreement. The filing lists shared voting and dispositive power; specific sole powers are reported as zero on the cover rows incorporated by reference.

Positive

  • None.

Negative

  • None.

Insights

Saba reports shared beneficial ownership of 4,401,171 shares (13.94%).

The filing states the Reporting Persons collectively hold 4,401,171 shares of Common Stock and Warrants with shared voting and dispositive power. The percentage is calculated using March 12, 2026 figures: 28,750,000 Shares outstanding plus 2,816,171 issuer‑share equivalents.

Holder decisions and warrant exercises will determine future trading; cash‑flow treatment and planned dispositions are not disclosed in the provided excerpt. Subsequent filings would disclose any changes in holdings or voting arrangements.

Shared beneficial interest 4,401,171 shares reported shared voting/dispositive power
Ownership percentage 13.94% calculated using March 12, 2026 denominator
Shares outstanding (denominator) 28,750,000 Shares as of <date>March 12, 2026</date>
Shares issuable upon warrants 2,816,171 Shares included in denominator per filing comment
CUSIP G63212107 Common Shares and Warrants class identifier
Shared Dispositive Power regulatory
"Shared Dispositive Power 4,401,171.00"
Joint Filing Agreement regulatory
"The Reporting Persons have entered into a Joint Filing Agreement, dated May 15, 2026"
Warrants issuable upon exercise financial
"2,816,171 Shares issuable upon the exercise of certain warrants held by the Reporting Persons"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G63212107

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,750,000 Shares outstanding as of March 12, 2026 as reported on the Issuer's 10-K filed with the Securities and Exchange Commission on March 12, 2026 plus (ii) 2,816,171 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,750,000 Shares outstanding as of March 12, 2026 as reported on the Issuer's 10-K filed with the Securities and Exchange Commission on March 12, 2026 plus (ii) 2,816,171 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,750,000 Shares outstanding as of March 12, 2026 as reported on the Issuer's 10-K filed with the Securities and Exchange Commission on March 12, 2026 plus (ii) 2,816,171 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G



Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:05/15/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:05/15/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:05/15/2026

Comments accompanying signature: *** Pursuant to a Power of Attorney dated as of November 16, 2015
Exhibit Information

Exhibit 1 - Joint Filing Agreement pursuant to Rule 13d-1(k).

FAQ

What stake does Saba Capital hold in MBAV?

Saba Capital and affiliated reporting persons report a shared interest of 4,401,171 shares, which the filing states equals 13.94% based on the filing's denominator calculation dated March 12, 2026.

How was the 13.94% ownership percentage calculated for MBAV?

The percentage uses a denominator of 28,750,000 Shares outstanding as of March 12, 2026 plus 2,816,171 shares issuable upon exercise of certain warrants held by the reporting persons, per the filing's comment.

Who are the reporting persons on the Schedule 13G for MBAV?

The reporting group includes Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, who signed a Joint Filing Agreement referenced in the filing.

Do the reporting persons have sole voting or dispositive power over the shares?

The cover rows incorporated by reference report 0 sole voting power and 0 sole dispositive power; the filing shows shared voting and shared dispositive power of 4,401,171 for each reporting person.

Are warrants included in the ownership calculation for MBAV?

Yes. The filing's percentage denominator explicitly includes 2,816,171 shares issuable upon exercise of certain warrants held by the reporting persons as stated in the comment on the cover rows.